Spironolactone
Product Images NDC 66336-916

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 66336-916). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dispensing Solutions, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Ndc 66336-0916-xx (Ndc 66336 0916 Xx Qualitest Pharmaceuticals)

Ndc 66336-0916-xx (Ndc 66336 0916 Xx Qualitest Pharmaceuticals)
This is a description of bulk source data including product ID, pedigree number, and cautionary notes for a medication called spironolactone 25mg. There are also multiple listings of the product under different RX numbers and lot numbers. The medication is in the form of white, round, film-coated tablets that may cause drowsiness and should be kept out of children's reach. It is recommended to be stored at 68-77°F and to avoid potassium supplements. The packaging is done by Dispensing Solutions in Santa Ana, CA.*
FDA Label Image

This Is The Structual Formula For Spironolactone. (Spironolactonetabs 1)

This Is The Structual Formula For Spironolactone. (Spironolactonetabs 1)
FDA Label Image

This Is Figure 1. Survival By Treatment Group In The Randomized Spironolactone Evaluation Study (Spironolactonetabs 2)

This Is Figure 1. Survival By Treatment Group In The Randomized Spironolactone Evaluation Study (Spironolactonetabs 2)
The text is not sufficient to generate a useful description as it only contains some statistical and time-related information.*
FDA Label Image

This Is An Image Of Figure 2. Hazard Ratios Of All-cause Mortality By Subgroup In The Randomized Spironolactone Evaluation Study (Spironolactonetabs 3)

This Is An Image Of Figure 2. Hazard Ratios Of All-cause Mortality By Subgroup In The Randomized Spironolactone Evaluation Study (Spironolactonetabs 3)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.